Ventilatory Management of the Preterm Neonate in the Delivery Room
2 other identifiers
interventional
112
1 country
1
Brief Summary
The purpose of this study is to evaluate sustained lung inflation followed by early nCPAP as delivery room ventilatory management for preterm neonates at risk of respiratory distress syndrome in reducing their need for mechanical ventilation and ameliorating lung injury without inducing adverse effects compared with intermittent bag and mask ventilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jan 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2010
CompletedFirst Posted
Study publicly available on registry
December 8, 2010
CompletedStudy Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedAugust 31, 2017
August 1, 2017
1.9 years
December 7, 2010
August 30, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Proportionate of neonates in each group who will need endotracheal intubation after failure of positive pressure ventilation through face mask in the delivery room.
2 minutes
Need for mechanical ventilation for neonates on nCPAP
28 days
Secondary Outcomes (10)
Occurrence and duration of oxygen therapy.
28 days
Bronchopulmonary dysplasia (BPD): defined as oxygen requirements more than 28 days.
28 days
Pulmonary air leaks
28 days
Patent ductus arteriosus (PDA).
7 days
Necrotizing enterocolitis (NEC).
28 days
- +5 more secondary outcomes
Study Arms (2)
Sustained lung inflation followed by CPAP
ACTIVE COMPARATORSustained pressure-controlled inflation using a neonatal mask and a T-piece ventilator (NeoPuff Infant Resuscitator; Fisher \& Paykel, Auckland, New Zealand). This will be followed by early CPAP.
Conventional self inflating bag and mask ventilation
ACTIVE COMPARATORIntermittent bag and mask ventilation using a self-inflating bag with an oxygen reservoir.
Interventions
After oropharyngeal and nasal suctioning, if there are no signs of spontaneous breathing or breathing is insufficient and/or heart rate is below 100 bpm, the following approach will be followed:Pressure-controlled (20 cm H2O) inflation will be sustained for 15 secs, using a neonatal mask and a T-piece ventilator (NeoPuff Infant Resuscitator; Fisher \& Paykel).To avoid pressure leakage, we will use a neonatal mask of appropriate size which adequately cover both the mouth and nostrils of infants. This pressure controlled inflation will be followed by CPAP at 5 Cm H2O.This procedure will be repeated a second time with a pressure of 25 cm H2O for 15 secs if breathing remained insufficient and/or the heart rate is \< 100 bpm and/or the infant is cyanotic. To be followed by CPAP at 6 Cm H2O.A third puff with a pressure of 30 cm H2O for 15 secs will be used after few seconds if inadequate heart rate and respiration was not reached. This will be followed by CPAP at 7 Cm H2O.
After oropharyngeal and nasal suctioning, if there is no signs of spontaneous breathing or breathing is insufficient and/or heart rate is below 100 bpm, intermittent mask and bag ventilation will be administrated at a rate 40-60 per minute using a self-inflating bag and mask with an oxygen reservoir.
Eligibility Criteria
You may qualify if:
- Preterm infants (gestational age \< 34 weeks)
You may not qualify if:
- \. Neonates with major congenital anomalies (congenital heart disease, neural tube defect, trisomy, etc.).
- Meconium aspiration syndrome, congenital diaphragmatic hernia and anterior abdominal wall defect.
- Maternal chorioamnionitis. 4.Neonates with gestational age \< 26 weeks and /or birth weight less than 750 grams.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gynecology and Obstetrics hospital, Ain-Shams University
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed Sami El Shimi, MD
Ain Shams University
- PRINCIPAL INVESTIGATOR
Hesham Abdel Samie Awad, MD
Ain Shams University
- PRINCIPAL INVESTIGATOR
Tarek Mohey El Gammacy, MD
Ain Shams University
- PRINCIPAL INVESTIGATOR
Ola Galal Badr El Deen, MD
Ain Shams University
- PRINCIPAL INVESTIGATOR
Dina Mohamed Mohamed Shinkar, MSc
Ain Shams University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
December 7, 2010
First Posted
December 8, 2010
Study Start
January 1, 2012
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
August 31, 2017
Record last verified: 2017-08